functional modifications observed during acute peritonineal permeability in a rat model of acute peritonitis.
observed in this condition. We have used a combination of expression, enzymatic and pharmacological studies to substandamentally, the transport of solutes across the peritotiate the potential role(s) played by NO during peritonitis.
neum during PD depends on the intrinsic permeability of promote angiogenesis [5, 6] , nitric oxide (NO) is increas-
Results. In comparison with controls, rats with acute peritonitis were characterized by inflammatory changes, increased ingly considered as a key mediator of peritoneal perme-S-nitrosocysteine immunoreactivity, and increased NOS activiability [7] [8] [9] . This hypothesis has been supported by ties in the peritoneum, due to the up-regulation of endothelial experiments showing an increase in peritoneal permeand inducible NOS. In parallel, rats with acute peritonitis ability with the NO donor nitroprusside in animal models showed increased permeability for small solutes; decreased [10] and stable PD patients [11] . sodium sieving; loss of ultrafiltration (UF); and increased protein loss in the dialysate. Addition of L-NAME to the dialysate Nitric oxide is produced from l-arginine by a family did not induce permeability changes in control rats, but signifiof NO synthase (NOS) isoforms that are expressed in a cantly improved UF and reversed permeability modifications large variety of tissues and cells [4, 6] . The neuronal and in rats with peritonitis. The effect of L-NAME was reflected endothelial NOS (nNOS and eNOS, respectively) are by a mild but consistent increase in blood pressure during PD exchange.
constitutive isoforms and their activity depends on the in- neum, and a significant NOS activity can be detected in peritoneum extracts [7, 9, 12] . The putative role played by NO during PD across the normal, non-infected peritoAcute peritonitis remains the most frequent and serineum remains controversial. Functional studies in rats ous complication of peritoneal dialysis (PD) [1] . The have shown that addition of the NOS inhibitor N trast, it has been suggested that permeability modifications during acute peritonitis might be the consequence  2001 by the International Society of Nephrology of increased NO production [7, 8] . This hypothesis was similar samples from the parietal and visceral peritoneum were processed for fixation in 4% paraformalderecently supported by studies demonstrating increased NOS activity and up-regulation of eNOS and iNOS durhyde and protein extraction as previously detailed [9, 12] . All experiments were conducted in accord with local ing peritonitis [9] .
The aim of this study was to perform a series of funcprescriptions and the NIH Guide for the Care and Use of Laboratory Animals. tional, biochemical and expression studies to test the effects of a specific inhibitor of NOS in a well-characterImmunohistochemistry ized rat model, in order to substantiate the role of NO in the regulation of peritoneal permeability.
Immunostaining was performed on 6-m peritoneal sections embedded in paraffin [9, 16] . After blocking in 0.3% H 2 O 2 and incubation with 10% normal serum, METHODS sections were incubated successively for 45 minutes each Rat model, PD protocol, tissue sampling with well-characterized monoclonal antibodies against eNOS and iNOS (Transduction Laboratories, LexingAdult (8-week-old) male Sprague-Dawley rats (Iffa Credo, Brussels, Belgium) weighing 279 Ϯ 2 g were ranton, KY, USA) [12] or polyclonal antibodies against S-nitrosocysteine (Alexis, Lausen, Switzerland) [17, 18] , domly assigned to control and peritonitis groups. As previously described [9] , peritonitis was induced by nonbiotinylated IgG (Vector Laboratories, Burlingame, CA, USA), and avidin-biotin peroxidase (Vector). Immunosterile implantation of a peritoneal catheter under anesthesia with SC Nembutal (Sanofi, Brussels; day 1) follabeling was visualized using aminoethylcarbazole (Vector). The specificity of the immunolabeling was conlowed for six days by a daily two-hour exchange with 15 mL of 1.36% glucose dialysate (Dianeal R ; Baxter, firmed by incubation without primary antibody; with non-immune mouse or rabbit IgG [9, 16] ; or after incubaNivelles, Belgium). Both catheter insertion and PD exchanges were performed without aseptic precautions, in tion with 0.2% HgCl 2 as indicated by the manufacturer (Alexis). Peritoneal sections stained with hemaluneosine order to reflect manipulation errors and touch contamination from the skin flora in PD patients [15] . Control or trichrome blue were used for systematic pathological examinations. rats matched for age and weight were left untouched for six days. All rats had access to standard chow and tap Western blot analyses water ad libitum. On day 7, control and peritonitis rats were anesthetized to perform a two-hour exchange PD Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting were perwith 15 mL of a 7% glucose dialysate (Dianeal) as described previously [9] . The NOS inhibitor L-NAME formed as described [9, 12, 16] . Efficiency of transfer to nitrocellulose was routinely tested by Ponceau red (Sigma, St. Louis, MO, USA) was added to the dialysate at concentrations ranging from 2.5 to 10 mmol/L, imme-(Sigma) staining and ␤-actin immunoreactivity (Sigma). The membranes were blocked for 30 minutes at room diately before instillation. Preliminary experiments have verified that variations of pH and osmolality correspondtemperature, followed by incubation with monoclonal antibodies raised against eNOS and iNOS at 4ЊC for 16 ing to the different L-NAME concentrations in the dialysate [13] do not influence peritoneal parameters in rats.
to 18 hours. After washing, the membranes were incubated for one hour at room temperature with peroxidaseBlood pressure was measured by means of a transducer (Pressure Set Uniflow type 43-600F; Bentley Laboralabeled secondary antibodies (Dako), before visualization with enhanced chemiluminescence (Amersham, tories Europe, Uden, The Netherlands) implanted in the carotid artery and connected to a Linearcorder polyLittle Chalfont, UK). Negative controls included incubation with non-immune mouse IgG (Dako). graph (Ankersmit, Groot-Bijgaarden, Belgium). Blood and dialysate samples were obtained before (T 0 ), at 30 NOS activity assay minutes (T 30 ), 60 minutes (T 60 ), and 120 minutes (T 120 ) of dwell time. Creatinine, hematocrit, glucose, sodium, Nitric oxide synthase enzymatic activities were measured using the l-citrulline assay as described [12] . potassium, total protein, osmolality, and enzymatic levels (transaminases, amylase, lipase, lactic dehydrogenase)
Briefly, 25 L of tissue extract (350 g of total protein) containing 20 mmol/L 3-[(3-cholamidopropyl) dimethylwere assayed by standard methods; white blood cells (WBC) in the dialysate (elts/L) were counted in a amminio] 1-propane sulfonate (CHAPS) were added to 200 L of Tris buffer (50 mmol/L, pH 7.4) containing Bü rker chamber; and dialysate cultures were obtained [9] . Rats with positive culture and WBC count in the 10 mmol/L dithiothreitol (DTT), 10 g/mL calmodulin, 1 mmol/L nicotinamide adenosine dinucleotide phosphate dialysate Ͼ1500 elts/L were considered to have peritonitis [12] . They represented 75% of the rats that had (NADPH), 4 mol/L flavin adenine dinucleotide (FAD), 4 mol/L flavin adenine mononucleotide (FMN), 2 been infected according to the protocol. At the end of the dwell, animals were sacrificed by exsanguination, and mol/L l-arginine, and 10 There was a significant, inverse correlation between the magnitude of UF and the severity of peritonitis as repH 5.5, containing 2 mmol/L ethylenediaminetetraacetic acid (EDTA), 0.2 mmol/L egtazic acid (EGTA), and 1 flected by WBC count in the dialysate (P ϭ 0.03
]-citrulline was separated by 0.31). Body weight, hematocrit, plasma creatinine, and cation-exchange chromatography (Bio-Rad) and quantiblood pressure at T 0 were similar in control and peritonified by liquid scintillation. The NOS activity (pmol cittis rats (Table 1) . Other biological parameters including rulline/mg protein/min) was determined by subtracting pancreatic and liver enzymes, as well as lactic dehydrogecounts obtained with or without 1 mmol/L L-NMMA.
nase levels, were similar in all groups (data not shown). Assays were performed with or without Ca 2ϩ to measure The addition of L-NAME to the dialysate in control and total versus the Ca 2ϩ -independent NOS activities, and peritonitis rats was reflected by an increase in blood calculate Ca 2ϩ -dependent NOS activity. Determinations pressure during the exchange, in contrast with the dewere performed in duplicate on three randomly selected crease observed when PD was performed with the 7% samples in each group.
glucose dialysate (Table 1) .
Data analysis
Peritoneum structure and reactivity for S-nitrosocysteine Data are presented as mean Ϯ SEM. Statistical significance was analyzed using the Student t test or oneMorphological examination of the visceral peritoneum way ANOVA, as appropriate.
( Fig. 1) showed that acute peritonitis in rats was reflected by a massive sub-mesothelial infiltrate of mononuclear cells, together with edema and vasodilation of the perito-RESULTS neal capillaries (Fig. 1 A, B) . Acute peritonitis was assoClinical and biological parameters ciated with capillary proliferation, as shown by the increased immunoreactivity for eNOS located in capillary In comparison with controls, rats with acute peritonitis were characterized by (a) decreased UF (1 Ϯ 1 vs. 7.6 Ϯ endothelium ( Fig. 1 C, D) . As previously reported [9] , a faint staining for iNOS was detected in mononuclear 0.5 mL, P Ͻ 0.001), (b) increased protein loss in the dialysate (4.7 Ϯ 0.9 vs. 0.8 Ϯ 0.1 g/L, P Ͻ 0.001), (c) cells infiltrating the peritoneum. It must be noted that the morphological and immunocytochemical observacloudy dialysate with an increased WBC count (9844 Ϯ 3335 vs. 313 Ϯ 35 elts/L, P ϭ 0.03), and (d) positive tions for NOS isoforms were similar in the visceral and parietal peritoneum, as illustrated previously [9] . Incubadialysate cultures. Analysis of the pathogens responsible for peritonitis showed a single organism in about 2/3 tion with L-NAME during the dwell did not affect immunostaining for eNOS in the peritoneum (Fig. 1E) , the of cases, and multiple germs in others. Gram-positive organisms were identified in 85% of cases, the remaining specificity of which was verified by absence of staining with control, non-immune mouse IgG (Fig. 1F) . The being gram-negative. The most frequent causative organism was Staphylococcus aureus, which accounted for 2/3 release of bioactive NO secondary to acute peritonitis was reflected by an increased immunoreactivity for of the cases, followed by coagulase-negative Staphylo- . Immunoreactivity for endothelial nitric oxide synthase (eNOS) is located in the endothelium lining peritoneal blood vessels in control rats (C). The staining intensity and the density of capillaries and blood vessels stained for eNOS are markedly increased in rats with peritonitis (D). The staining pattern for eNOS is not modified when rats with peritonitis are treated with 5 mmol/L L-NAME in the dialysate (E). The specificity of the immunostaining for eNOS is demonstrated by the lack of signal when incubation is performed with control mouse IgG (F ). Representative sections of the visceral peritoneum of control rats (G) and rats with peritonitis (H) stained for S-nitrosocysteine. A major increase in the immunoreactivity is observed in rats with peritonitis, particularly located in the mesothelial and endothelial cell layers. The inset demonstrates the intense immunoreactivity for S-nitrosocysteine in the endothelium lining peritoneal capillaries. A similar staining pattern for S-nitrosocysteine is observed in the peritoneum of peritonitis rats that have been treated with L-NAME (I ) (original magnification A-H, ϫ350; inset, ϫ485; I, ϫ380). (Fig. 1 G, H) , which peritoneum was reflected by a significant increase in total NOS activity (0.39 Ϯ 0.04 vs. 0.12 Ϯ 0.06 pmol citrulwas particularly concentrated in mesothelial and endothelial cells (Fig. 1H, inset) . Incubation with L-NAME line/mg protein/min, P Ͻ 0.01), due to both Ca 2ϩ -dependent and Ca 2ϩ -independent NOS isoforms (Fig. 2B) . The during the dwell did not affect the immunostaining for S-nitrosocysteine (Fig. 1I) .
S-nitrosocysteine in the peritoneum
presence of NOS inhibitor L-NAME in the peritoneum extracts during the l-citrulline assay prevented reliable NOS expression and enzymatic activities in measurements of NOS activities in control and peritonithe peritoneum tis rats treated with L-NAME.
Immunoblot analyses confirmed that acute peritonitis
Peritoneal permeability induced a significant up-regulation of both the endothelial (140 kD) and inducible (130 kD) NOS isoforms in Acute peritonitis induced a major increase in peritoneal permeability for small solutes such as urea (Fig.  the peritoneum (Fig. 2A) . As previously described [9] , induction of iNOS was variable in intensity, ranging from 3A), a faster glucose absorption from the dialysate (Fig.  3B) , and a reduced free-water permeability (as attested weak to very strong ( Fig. 2A, lower band of the gel) . As expected, the up-regulation of NOS isoforms in the by the loss of sodium sieving, Fig. 3C ). These changes , to distinguish between Ca 2ϩ -dependent ( ) and Ca 2ϩ -independent (ᮀ) NOS activities. Total NOS activity is increased (ϳ3-fold) in rats with peritonitis. The increased NOS activity results from both Ca 2ϩ -dependent and Ca 2ϩ -independent NOS. *P Ͻ 0.05 between peritonitis and control rats.
were reflected by a fall in UF and an increased protein loss in the dialysate (cf. above, Fig. 4 A, B) , as well as an increased cumulative urea transport during the two hour dwell (Fig. 4C) .
Addition of 5 mmol/L L-NAME to the dialysate in control rats did not change peritoneal permeability parameters (Fig. 3) , and was not reflected by significant changes in UF (Ϫ vs. ϩ L-NAME: 7.6 Ϯ 0.5 vs. 8.8 Ϯ 0.5 mL) and protein loss in the dialysate (Ϫ vs. ϩ L-NAME: 0.8 Ϯ 0.1 vs. 1 Ϯ 0.1 g/L). In contrast, addition of 5 mmol/L L-NAME to the dialysate in rats with acute Fig. 3 . Effect of L-NAME on functional parameters of peritoneal dialysis peritonitis significantly reduced the hyperpermeability in control and peritonitis rats. The dialysate-to-plasma (D/P) ratio of urea to urea and glucose (Fig. 3 A, B) , and significantly im-(A) and sodium (C), and the progressive removal of glucose from the proved the dialysate-over-plasma ratio for sodium ( Fig.   dialysate (D/D 0 , B) were determined in control rats (ᮀ, ᭝), and rats with peritonitis (, ᭡) during a two-hour exchange with 15 mL of 7% glucose 3C). Also, treatment with L-NAME in rats with acute supplemented (᭝, ᭡) or not (ᮀ, ) with 5 mmol/L L-NAME. All parameperitonitis induced a significant increase in the dialysateters were obtained for 6 rats in each group. Acute peritonitis induces a over-plasma ratio for osmolality at T 30 , from 2.29 Ϯ 0.02 significant increase in permeability for urea and glucose, and a loss of sodium sieving (*P Ͻ 0.05 vs. C). These modifications are significantly (P) to 2.34 Ϯ 0.02 (P-LA5) and further to 2.42 Ϯ 0.03 reduced when L-NAME is added to the dialysate (#P Ͻ 0.05 vs. P).
(P-LA10).
The effect of L-NAME on UF was maximal at 2.5 mmol/L (Fig. 4A) , whereas the effect on protein loss and permeability for urea was dose-dependent and maximal at 10 mmol/L (Fig. 4 B, C) .
DISCUSSION
This study used a well-characterized model of acute peritonitis in rats to demonstrate that local generation of NO, secondary to the up-regulation of NOS isoforms, induces major, detrimental changes in peritoneal permeability. These functional changes are partially reversed by acute NOS inhibition, whereas structural modifications associated with the release of NO (formation of S-nitrosocysteine) are not affected. In contrast, the lack of functional consequences of NOS inhibition in control rats suggests that NO does not influence significantly peritoneal permeability in stable, uninfected PD.
Analogues of l-arginine can inhibit the production of NO by NOS isoforms. L-NAME has proven to be one of the most useful NOS inhibitors due to its low cost, commercial availability, chemical stability, solubility in water, and effectiveness in the millimolar range both for tissue studies and in vivo investigations [13, 19, 20] . Because previous studies have shown that local, intraperitoneal production of NO might be critical for regulating PD parameters [7] [8] [9] 13 ], we postulated that administration of L-NAME in the dialysate was probably more relevant than systemic infusion, which induces acute and severe hypertension [21] . Nevertheless, hemodynamic monitoring revealed that rats treated with L-NAME in the dialysate had a mild but consistent increase in systolic blood pressure during the exchange, which contrasts with the drop observed in absence of L-NAME (Table 1) . Addition of L-NAME to the dialysate did not induce other clinical or biological side effects, and did not alter the morphology of the peritoneum. In particular, morphological examination confirmed the absence of congestion, infarction, or infiltrate in control rats treated with L-NAME.
A modified peritoneal equilibration test [9] was used to investigate the effects of L-NAME on peritoneal permeability ( Fig. 2A) . Addition of 5 mmol/L L-NAME to the dialysate in control rats did not affect UF and protein loss in the dialysate significantly, and was not associated (Fig. 3) . The lack of effect of dialysate on ultrafiltration (A), protein loss (B), and urea permeability NOS inhibition on the permeability for small solutes is [14] and control Wistar rats [13] . Taken the curve for the 120 min-dwell, in min) in control rats (C, ᮀ) and rats together, these results suggest that the very low levels with acute peritonitis (P), untreated () or treated ( ) with different doses of L-NAME (2.5, 5 and 10 mmol/L) in the dialysate (*P Ͻ 0.05 of bioactive NO generated by the peritoneum during vs. C; #P Ͻ 0.05 vs. P).
stable uninfected PD [9, 12] do not critically affect peritoneal permeability.
The situation is strikingly different in acute peritonitis. In comparison with controls, rats with peritonitis were characterized by: structural modifications in the peritoand, via S-nitrosylation, regulate proteins such as recepneum (Fig. 1) ; up-regulation of eNOS and iNOS, paraltors, enzymes, ion channels, and transcription factors leled by increased NOS activities in the peritoneum (Fig.  [24] . The concentration of S-nitrosocysteine reactivity in 2); increased permeability for urea and glucose, and loss endothelial cells (Fig. 1 ) might be relevant when considof free-water permeability (Fig. 3) ; and the combination ering the potential interaction of NO with the critical of decreased UF and increased protein loss in the dialycysteine 189 within aquaporin-1 (AQP1), the molecular sate (Fig. 4) . These changes, which confirm our previous counterpart of the ultrasmall pore in the endothelium observations in this model [9] , are characteristic of acute [25] . Indeed, recent structural data on AQP1 [26] confirm peritonitis [2] . Furthermore, bacteriological findings in that this cysteine 189 is flanked by consensus motifs rats with peritonitis are similar to the situation encoun-(acidic and/or basic residues) for S-nitrosylation [27] . tered in PD-related peritonitis, particularly in case of Arguably, the persistence of S-nitrosocysteine reactivity touch contamination from skin flora [15] .
implies that biochemical and/or structural conditions inRecent studies have suggested that increased EPSA volved in NO-induced modifications were not modified and functional modifications observed in acute peritoniby acute incubation with L-NAME. Finally, L-NAME tis might be the consequence of increased NO production may inhibit constitutive NOS isoforms preferentially mediated by the up-regulation of NOS isoforms in the over iNOS [28] , which might explain its partial effect in peritoneum [7] [8] [9] . This hypothesis was supported by the a situation characterized by the up-regulation of both effect of L-NAME on peritoneal permeability for small eNOS and iNOS (Fig. 2) . Studies in mouse models lacksolutes and proteins in rats treated with lipopolysacchaing specific NOS isoforms will be necessary to delineate rides from E. coli [13] . Our expression and enzymatic the precise involvement of each NOS isoform in the studies (Figs. 1 and 2) confirm that peritonitis induces a pathophysiological changes observed. major increase in NOS activity and up-regulates both
Thus, our results demonstrate that inhibition of NOS eNOS and iNOS in the peritoneum. As described earlier in the peritoneum during acute peritonitis significantly [12] , the induction of iNOS is variable in intensity and improves UF and reduces protein loss in the dialysate. related to the severity of the peritonitis (as reflected by
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